SCHEMBL6876336

SCHEMBL6876336

COCCNc1ccc(OC)c2nc(N)sc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ NCF1 P14598 2/20 0.40
▸ ALDH1A1 P00352 7/20 0.40
▸ PTGER4 P35408 2/20 0.39
▸ ADORA2A P29274 1/20 0.38
▸ ADORA2B P29275 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ CHRM4 P08173 1/20 0.37
▸ GAK O14976 1/20 0.36
▸ HPGD P15428 3/20 0.36
▸ TSHR P16473 3/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ HSD17B10 Q99714 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13475603 0.87 CYP3A4 (0.43) CYP3A4TDP1ALDH1A1ADORA2AADORA2B
SCHEMBL6868648 0.85 CYP3A4 (0.47) CYP3A4TDP1ALDH1A1ADORA2AADORA2B
SCHEMBL6877721 0.80 CYP3A4 (0.50) CYP3A4TDP1ALDH1A1ADORA2AADORA2B
SCHEMBL6875716 0.80 CYP3A4 (0.45) CYP3A4TDP1NCF1ALDH1A1ADORA2A
SCHEMBL4128905 0.78 ALDH1A1 (0.61) CYP3A4TDP1ALDH1A1KDM4EMAPT
SCHEMBL3057508 0.75 ADORA2A (0.61) CYP3A4TDP1ALDH1A1ADORA2AADORA2B
SCHEMBL6875429 0.74 TDP1 (0.56) CYP3A4TDP1ALDH1A1KDM4EMAPT
SCHEMBL5713537 0.73 ADORA2B (0.44) CYP3A4TDP1ALDH1A1ADORA2AADORA2B
SCHEMBL5206462 0.72 ALDH1A1 (0.56) CYP3A4TDP1ALDH1A1MAPTLMNA
SCHEMBL3042793 0.71 CYP3A4 (0.53) CYP3A4TDP1ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1456188-A1 7-AMINO-BENZOTHIAZOLE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2004-09-15 — — EP disclosed
US-6713499-B2 ADENOSINE RECEPTOR AGONIST HOFFMAN-LA ROCHE INC. 2004-03-30 — — US disclosed
US-20030153566-A1 7-Amino-benzothiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 — — US disclosed
WO-2003053946-A1 7-AMINO-BENZOTHIAZOLE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2003-07-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153566-A1 7-Amino-benzothiazole derivatives ADORA1, ADORA2A, ADORA3 CYP3A4 954/4885TDP1 2594/4885NCF1 2816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback